ABUS - Arbutus Biopharma Corp
3.23
-0.070 -2.167%
Share volume: 640,237
Last Updated: 05-09-2025
Pharmaceutical Products/Pharmaceutical Preparations:
-0.09%
PREVIOUS CLOSE
CHG
CHG%
$3.30
-0.07
-0.02%
Summary score
38%
Profitability
35%
Dept financing
25%
Liquidity
58%
Performance
40%
Sector
Manufacturing
Industry
Pharmaceutical Products/Pharmaceutical Preparations
Long-term ratios 31-Dec-2020 - 31-Dec-2024
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-17.8%
Return on assets
-10.96%
Return on sales
-662.99%
Return on invested capital
-272.92%
Total debt ratio
25.04%
Debt ratio change over timeo
-1.22%
Current Ratio
8.15%
Quick Ratio
14.2%
Cash Position Ratio
4.62%
Short-term ratios 31-Dec-2023 - 31-Dec-2024
The data are presented for the financials results of the quarters of the last year.
Return on equity
0%
Return on assets
-13.06%
Return on sales
-1250.19%
Return on invested capital
0%
Total debt ratio
24.29%
Debt ratio change over timeo
0%
Current Ratio
7.11%
Quick Ratio
0%
Cash Position Ratio
2.23%
Last quarter ratios 31-Dec-2024
The data are presented for the financials results of the last quarter.
Return on equity
0%
Return on assets
-10.6%
Return on sales
-885.2%
Return on invested capital
0%
Total debt ratio
26.07%
Debt ratio change over time
0%
Current Ratio
8.15%
Quick Ratio
0%
Cash Position Ratio
2.33%
Performance ratios (change over 4 years) 31-Dec-2020 - 31-Dec-2024
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-86.69%
Return on assets
-91.9%
Return on sales
295.41%
Return on invested capital
-40.48%
Total debt ratio
-121.7%
Debt ratio change over time
-1.22%
Current Ratio
-10.94%
Quick Ratio
-11.44%
Cash Position Ratio
-9.78%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | ABUS | LLY | JNJ | NVO |
|---|---|---|---|---|
| Return on equity | -17.8% | 14.82% | 9.25% | 0% |
| Return on assets | -10.96% | 4.21% | 3.01% | 0% |
| Return on sales | -662.99% | 27.61% | 25.13% | 0% |
| Return on invested capital | -272.92% | 8.25% | 9.21% | 0% |
| Profitability | 0% | 97% | 81% | 0% |
| Total debt ratio | 25.04% | 81.46% | 59.72% | 0% |
| Debt ratio change over time | -1.22% | -9.8% | -49.67% | 0% |
| Dept financing | 8% | 25% | 18% | 25% |
| Current Ratio | 7.11% | 1.22% | 1.1% | 0% |
| Quick Ratio | 0% | 0.94% | 0.86% | 0% |
| Cash Position Ratio | 2.23% | 0.13% | 0.46% | 0% |
| Liquididy | 75% | 6% | 8% | 0% |
| Short-term ratios | ABUS | LLY | JNJ | NVO |
|---|---|---|---|---|
| Return on equity | 0% | 0% | 0% | 0% |
| Return on assets | -13.06% | 4.34% | 2.26% | 0% |
| Return on sales | -1250.19% | 28.22% | 23.48% | 0% |
| Return on invested capital | 0% | 0% | 0% | 0% |
| Profitability | 50% | 50% | 34% | 0% |
| Total debt ratio | 24.29% | 81.06% | 60.18% | 0% |
| Debt ratio change over time | 0% | 0% | 0% | 0% |
| Dept financing | 32% | 25% | 19% | 0% |
| Current Ratio | 7.11% | 1.22% | 1.1% | 0% |
| Quick Ratio | 0% | 0.94% | 0.86% | 0% |
| Cash Position Ratio | 2.23% | 0.13% | 0.46% | 0% |
| Liquididy | 50% | 31% | 32% | 0% |
